These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 32242357)

  • 21. The Drivers of Acute and Long-term Care Clostridium difficile Infection Rates: A Retrospective Multilevel Cohort Study of 251 Facilities.
    Brown KA; Daneman N; Jones M; Nechodom K; Stevens V; Adler FR; Goetz MB; Mayer J; Samore M
    Clin Infect Dis; 2017 Oct; 65(8):1282-1288. PubMed ID: 28595289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time trends and predictors of laboratory-confirmed recurrent and severe
    Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
    CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013.
    Kotila SM; Mentula S; Ollgren J; Virolainen-Julkunen A; Lyytikäinen O
    Emerg Infect Dis; 2016 Oct; 22(10):1747-1753. PubMed ID: 27648884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interfacility patient sharing and
    Brown KA; McGeer A; Schwartz KL; Diong C; Etches J; Garber G; Johnstone J; Langford B; Daneman N
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):154-160. PubMed ID: 31762432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incidence, clinical characteristic and evolution of Clostridioides difficile infection].
    Jorge L; Azula N; Smayevsky J; Herrera F; Temporiti E; Bonvehí P
    Medicina (B Aires); 2021; 81(6):931-938. PubMed ID: 34875590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset,
    Puri S; Hughes HY; McCrackin MD; Williford R; Gebregziabher M; Salgado CD; Curry SR
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):467-468. PubMed ID: 31973777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L; Barrón R; Pérez JL; Mena A
    Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital-acquired
    Vader DT; Weldie C; Welles SL; Kutzler MA; Goldstein ND
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):948-954. PubMed ID: 33280624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between epidemiologic case definition categories and adverse clinical outcome in patients with Clostridiodes difficile infection in San Francisco County, California: a five-year retrospective cohort study.
    Siraw BB; Reingold AL; Meyahnwi D
    BMC Infect Dis; 2023 Feb; 23(1):68. PubMed ID: 36737685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.
    Hunter JC; Mu Y; Dumyati GK; Farley MM; Winston LG; Johnston HL; Meek JI; Perlmutter R; Holzbauer SM; Beldavs ZG; Phipps EC; Dunn JR; Cohen JA; Avillan J; Stone ND; Gerding DN; McDonald LC; Lessa FC
    Open Forum Infect Dis; 2016 Jan; 3(1):ofv196. PubMed ID: 26798767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
    Okafor CM; Clogher P; Olson D; Niccolai L; Hadler J
    Emerg Infect Dis; 2023 May; 29(5):877-87. PubMed ID: 37081745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily.
    Medaglia AA; Buffa S; Gioè C; Bonura S; Rubino R; Iaria C; Colomba C; Cascio A
    Infection; 2021 Dec; 49(6):1221-1229. PubMed ID: 34495497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-acquired Clostridioides difficile infections in Alberta: The validity of laboratory-identified event surveillance versus clinical infection surveillance.
    Almond J; Leal J; Bush K; Rogers E; Henderson EA; Ellison J
    Am J Infect Control; 2020 Jun; 48(6):633-637. PubMed ID: 31733811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study.
    Karaoui WR; Rustam LBO; Bou Daher H; Rimmani HH; Rasheed SS; Matar GM; Mahfouz R; Araj GF; Zahreddine N; Kanj SS; Berger FK; Gärtner B; El Sabbagh R; Sharara AI
    J Infect Public Health; 2020 Apr; 13(4):485-490. PubMed ID: 31838001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One Health approach to Clostridioides difficile in Japan.
    Usui M
    J Infect Chemother; 2020 Jul; 26(7):643-650. PubMed ID: 32334949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Clostridium difficile infection on pediatric appendicitis.
    Orelaru F; Karabon P; Novotny N; Akay B; Brahmamdam P
    Pediatr Surg Int; 2021 Jul; 37(7):865-870. PubMed ID: 33830299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.